Related references
Note: Only part of the references are listed.Interleukin-1β-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression
Ryota Takahashi et al.
GUT (2021)
Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence
Vidya P. Nimbalkar et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
E. A. Rozeman et al.
NATURE MEDICINE (2021)
Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer
Zaoqu Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Clinical Significance and Inflammatory Landscape of a Novel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
Zaoqu Liu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions
Masahiro Kagabu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Distinct Expression Patterns of Two Tumor Necrosis Factor Superfamily Member 15 Gene Isoforms in Human Colon Cancer
Tomasz Jerzy Slebioda et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung Cancer
Marcelo V. Negrao et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
SERPINA3 is a key modulator of HNRNP-K transcriptional activity against oxidative stress in HCC
Eunkyong Ko et al.
REDOX BIOLOGY (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma
Chuanjie Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer
Song Ee Park et al.
ONCOIMMUNOLOGY (2018)
SAC3D1: a novel prognostic marker in hepatocellular carcinoma
Myoung-Eun Han et al.
SCIENTIFIC REPORTS (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer
Emeka K. Enwere et al.
MODERN PATHOLOGY (2017)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Increased expression of PD-L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity
Chaoqi Liu et al.
MOLECULAR MEDICINE REPORTS (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
D. P. Carbone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients
Dingyuan Luo et al.
ONCOTARGETS AND THERAPY (2017)
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
Martin Lauss et al.
NATURE COMMUNICATIONS (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Immunotherapy and targeted therapy for cervical cancer: an update
Gulden Menderes et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
The role of neoantigens in response to immune checkpoint blockade
Nadeem Riaz et al.
INTERNATIONAL IMMUNOLOGY (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
PD-L1 expression in human cancers and its association with clinical outcomes
Xin Wang et al.
ONCOTARGETS AND THERAPY (2016)
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian et al.
NATURE REVIEWS CANCER (2016)
Classifying Cancers Based on T-cell Infiltration and PD-L1
Michele W. L. Teng et al.
CANCER RESEARCH (2015)
Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers
Louisa Mezache et al.
MODERN PATHOLOGY (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Functional Genetic Variants of TNFSF15 and Their Association with Gastric Adenocarcinoma: A Case-Control Study
Zhi Zhang et al.
PLOS ONE (2014)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
CCL4L Polymorphisms and CCL4/CCL4L Serum Levels Are Associated with Psoriasis Severity
Edurne Pedrosa et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Copy number variation in the CCL4L gene is associated with susceptibility to acute rejection in lung transplantation
R. Colobran et al.
GENES AND IMMUNITY (2009)
The genomic landscapes of human breast and colorectal cancers
Laura D. Wood et al.
SCIENCE (2007)
The consensus coding sequences of human breast and colorectal cancers
Tobias Sjoeblom et al.
SCIENCE (2006)
Cervical cancer as a priority for prevention in different world regions: An evaluation using years of life lost
BH Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Share Paper
